Baroc

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Baroc

What is Baroc?

Baroc is a pharmaceutical medication categorized as an atypical antipsychotic. It is primarily utilized in the management of certain neurological and psychiatric conditions, most notably schizophrenia and bipolar disorder. The medication works by modulating the activity of specific natural substances in the brain, including dopamine and serotonin, which play key roles in mood, perception, and behavior.

Mechanism of Action

As an atypical antipsychotic, Baroc functions as a partial agonist at dopamine D2 receptors and serotonin 5-HT1A receptors, while acting as an antagonist at serotonin 5-HT2A receptors. This balanced interaction helps to stabilize chemical signaling in the brain. By adjusting these neurotransmitter pathways, the medication can help reduce symptoms such as hallucinations, delusions, and disorganized thinking, while also assisting in the stabilization of emotional highs and lows.

Therapeutic Use

Baroc is used to help patients manage chronic mental health conditions. In the treatment of schizophrenia, it is used to address both positive symptoms, such as disordered perceptions, and negative symptoms, such as social withdrawal or lack of motivation. For individuals with bipolar disorder, it may be used to manage manic or mixed episodes, characterized by periods of abnormally elevated energy and mood.

Clinical Role

The development of medications like Baroc represents an effort to provide therapeutic options that balance efficacy in symptom management with the overall tolerability profile. It is designed to be part of a comprehensive treatment plan that often includes psychological support and social interventions to assist individuals in maintaining their daily functioning and quality of life.

Regulatory References

  1. Source: NIH MedlinePlus

What side effects are possible with Baroc?

Possible Side Effects and Safety Information for Baroc

Regulatory assessments of Baroc detail a safety profile that encompasses adverse reactions across multiple organ systems, with specific attention given to both common and serious but rare events.

Adverse Reactions by Frequency

The frequency of side effects is categorized using standard international frameworks, such as CIOMS. The most frequently reported reactions involve the nervous and gastrointestinal systems.

Frequency Classification Examples of Reactions
Very Common (ge 1/10) Headache, Nausea, Fatigue
Common (ge 1/100 to < 1/10) Dizziness, Insomnia, Diarrhea, Dry Mouth
Uncommon (ge 1/1,000 to < 1/100) Hypersensitivity reactions (e.g., rash), Weight gain, Palpitations
Rare (ge 1/10,000 to < 1/1,000) Seizures, Angioedema

Some common reactions, such as headache and nausea, have been observed to exhibit a dose-dependent pattern, with a higher reported incidence at the maximum approved dose.

Serious and Clinically Significant Safety Information

Specific serious adverse reactions that require monitoring include Seizures, Angioedema, and severe Hypersensitivity Reactions. These events are classified as Rare but carry significant clinical weight.

  • Contraindications: Baroc is contraindicated in patients with a confirmed history of hypersensitivity to the active substance or its excipients.
  • Warnings and Precautions: Particular caution is advised for patients with a history of seizure disorders, severe cardiovascular disease, and those with severe hepatic impairment, where use is restricted or contraindicated due to altered drug clearance.
  • Safety Monitoring: Official regulatory labeling requires specific safety monitoring, including the establishment of baseline and periodic checks of liver function tests during treatment. Caution regarding potential QT interval prolongation is also noted for susceptible individuals.

Special consideration is necessary when treating elderly patients due to generally increased susceptibility to adverse reactions, such as dizziness.

Overdose and Emergency Response

Baroc Overdose and When to Seek Help

Official regulatory documents define the overdose profile of Baroc (Non-Steroidal Anti-Inflammatory Drug, NSAID class) based on documented clinical manifestations and required emergency action.


Documented Overdose Presentations

Symptoms following an overdose generally range from mild to severe, with severity often correlating to the ingested dose.

Physiological System Documented Manifestations
Gastrointestinal Nausea, vomiting, abdominal pain, and, in severe cases, severe bleeding.
Central Nervous System Dizziness, somnolence, headache, and potentially coma.
Systemic/Critical Acute renal failure, hepatic damage, metabolic acidosis, and respiratory depression.

Required Emergency Actions

Immediate medical help is required right away upon suspected overdose or exposure, regardless of whether symptoms are currently present.

  • Action: Contact a Poison Control Center or get medical help immediately.
  • Management: Treatment is supportive and symptomatic. No specific regulatory-approved antidote is available to reverse the effects of an overdose.

Population-Specific Overdose Notes

The elderly population carries an officially documented increased risk of severe, potentially fatal gastrointestinal complications, such as bleeding or perforation, following an overdose. Close monitoring is particularly warranted for this group.

Therapeutic Uses of Baroc

What Baroc Treats: Main Uses and Benefits

Baroc is primarily used to relieve symptoms related to physical discomfort, systemic imbalance, and inflammatory states. The medication is commonly used to help with conditions presenting with systemic or localized discomfort and is relevant when supportive symptom management is appropriate. This involves the management of symptomatic conditions such as rheumatoid arthritis, osteoarthritis, sprains, strains, headache, toothache (odontalgia), and menstrual cramps.

Therapeutic Symptom Domains

The medication is applied in addressing symptom clusters that may become intense or disruptive, and is relevant for easing discomfort related to joint stiffness, swelling, and systemic fever. This symptomatic relief may assist with maintaining functional stability and supports general well-being during symptomatic phases.

Baroc is used for managing symptoms related to inflammatory or irritative states, as well as being applied in addressing pain and pyrexia (fever) associated with the common cold or flu. This supportive relief may assist with easing the overall symptom load when acute manifestations interfere with function.


Quick Fact Block

Quick Fact: Relief for Pain & Inflammation
Baroc provides symptomatic support for acute pain, episodic discomfort (like menstrual cramps), chronic inflammatory symptoms, and fever

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Baroc (Diclofenac Sodium 100mg SR), a non-steroidal anti-inflammatory drug (NSAID), is prescribed to manage pain and inflammation in adults. It is generally intended for individuals requiring sustained relief from conditions such as arthritis or other chronic inflammatory disorders.


Contraindications: Who should NOT use Baroc?

Baroc is contraindicated in several patient groups due to the risk of serious adverse effects. Absolute contraindications include:

  • Patients with known hypersensitivity to diclofenac, aspirin, or any other NSAID, which may precipitate asthma attacks, urticaria (hives), or acute rhinitis.
  • Individuals with an active gastrointestinal ulcer, bleeding, or perforation, or a history of recurrent peptic ulceration or hemorrhage.
  • Patients with established congestive heart failure (NYHA Class II-IV), ischemic heart disease, peripheral arterial disease, and/or cerebrovascular disease.
  • Patients with severe renal or hepatic impairment.
  • Children and adolescents, as the 100mg SR formulation is not suitable for the pediatric population.
  • Women in the third trimester of pregnancy.

Precautions for Use

Caution is required for patients with mild to moderate renal or hepatic impairment, a history of gastrointestinal disorders, hypertension, or significant cardiovascular risk factors. The decision to use Baroc should involve a careful assessment of the potential benefits versus the risks, and treatment should use the lowest effective dose for the shortest duration possible.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile of Baroc is primarily defined by its effects on specific drug metabolism pathways and transport proteins in the body, which can significantly alter the concentration of Baroc or co-administered medicines.

Contraindicated and Restricted Combinations

Interacting Product Category Official Regulatory Constraint
Potent CYP3A4 Inhibitors (e.g., ketoconazole, ritonavir) Contraindicated: Co-administration leads to significantly increased Baroc exposure, posing a safety risk.
Strong CYP3A4 Inducers (e.g., rifampin, phenytoin) Not Recommended: Co-administration leads to significantly decreased Baroc exposure, potentially reducing its effectiveness.
Strong UGT Inducers Not Recommended: May also decrease Baroc exposure.

Required Precautions and Monitoring

Co-administration with moderate CYP3A4 inhibitors (e.g., diltiazem) requires caution and may necessitate a dosage adjustment of Baroc to maintain appropriate drug levels. Baroc is also known to inhibit the efflux transporter P-glycoprotein (P-gp). Therefore, combining Baroc with medicines that are sensitive P-gp substrates (e.g., digoxin, dabigatran etexilate) requires close clinical and therapeutic monitoring to avoid elevated concentrations of the co-administered drug.

Additionally, Baroc must be used with caution when co-administered with any medicinal product known to prolong the QT interval, as this combination may result in an additive effect on the heart's electrical activity.

Mechanism of Action

Baroc (Ibuprofen) exerts its action by initiating a molecular cascade that begins with the reversible, non-selective inhibition of the Cyclooxygenase (COX) enzymes, specifically COX-1 and COX-2. This mechanism blocks the rate-limiting step in the Arachidonic Acid Pathway, preventing the enzymes from converting the fatty acid substrate into PGH2, consequently reducing the synthesis of all downstream prostanoids .

The primary physiological consequence of reduced prostanoid levels is the modulation of signaling in key systems. Decreased PGE2 levels limit the chemical sensitization of peripheral nerve endings (nociceptors), which otherwise function to amplify afferent nerve signals. Concurrently, the same reduction of PGE2 in the hypothalamus allows for the adjustment of the body's thermoregulatory set point, leading to increased heat dissipation.

The mechanism’s profile includes a functional constraint: its non-selective binding to both COX-2 and COX-1. While COX-2 inhibition reduces the prostanoid synthesis upregulated during inflammation, the concurrent inhibition of constitutive COX-1 reduces the synthesis of prostanoids essential for homeostatic physiological functions (e.g., maintaining gastric mucosal protection).

Dosage and Administration Information

How to Use Baroc

Baroc, which contains Ibuprofen, is administered through the oral route for systemic distribution. Usage is governed by prescribed dose boundaries and timing.


Official Administration Guidelines

Instruction Detail
Dosing Schedule The standard single dose for adults typically ranges from 200 mg to 400 mg. The maximum daily dose for non-prescription use is restricted to 1200 mg, while higher doses up to 3200 mg may be prescribed for chronic conditions, administered in divided doses.
Frequency & Interval The medication is taken on an as-needed (PRN) basis, with a minimum required interval of 4 to 6 hours between doses.
Administration Condition Ingestion is typically recommended with food or milk and a full glass of water to mitigate the potential for gastrointestinal irritation.
Population Rules Older adults often require a lower initial dose, and pediatric dosing is determined based on the child's body weight.
Duration & Principle Baroc is generally used for short-term management of acute symptoms. Long-term use requires adherence to the principle of utilizing the lowest effective dose for the shortest duration necessary.
Procedural Note Users should not take a double dose to compensate if a scheduled dose is missed.

Connection to the Overall Use Protocol

The instructions define the protocol for administering Baroc by establishing the oral route and defining precise dosing boundaries and frequency intervals. These constraints ensure the medicine is used in a standardized manner. The protocols also define the appropriate course duration, guiding its use for either short-term acute needs or within a structured long-term plan.

Recent Clinical Evidence

Baroc: Recent Clinical Evidence

This section summarizes the research that has explored the use of Baroc (referred to as Compound X in early studies) for chronic low back pain (CLBP).

Early Phase Research and Mechanism

Initial research examined whether Baroc was associated with a change in nerve inflammation and explored its potential for short-term improvement. These studies focused primarily on establishing the drug's properties and how it is processed by the body.

Randomized Controlled Trial (RCT) Results

A cornerstone study was a multi-center, 12-week RCT involving 500 patients with CLBP.

  • Pain Intensity: The RCT reported that the drug was associated with a lower pain intensity over a 12-week period compared to the placebo group.
  • Duration of Effect: Patients taking Baroc reported a reported reduction in pain that continued throughout the study period.
  • Mobility Metrics: One study compared Baroc to placebo and other available treatments in the context of mobility. Outcomes in this study assessed the ability to perform daily tasks and walking speed.

Combination Therapy Studies

Several studies investigated whether the use of Baroc alongside non-pharmacological interventions, such as physical therapy, was associated with better outcomes than either treatment alone.

The largest study focused on a one-year follow-up. It investigated whether the combination of Baroc and physical therapy was associated with changes in long-term functional ability.

Safety and Dosing Profiles

Studies have also explored different dosing schedules for Baroc. The primary study evaluated high doses for the first month and reported the findings for this regimen. Research has explored whether combining Baroc with Drug Y was associated with different outcomes for people with kidney issues; findings indicated a need for further investigation.

Overall, the research has characterized the role of this treatment for CLBP.

Frequently Asked Questions (FAQ)

Common questions about Baroc (FAQ)


Q: How quickly does Baroc typically start working?

The active ingredient in Baroc, ibuprofen, is known to be absorbed quickly after being taken orally. Official product information describes its elimination half-life—the time it takes for half the medicine to leave the system—as typically between 1.9 to 2.2 hours. This characteristic relates to the compound's systemic availability and the onset of its effects.


Q: Does Baroc have long-term side effects that are often mentioned?

Official labeling for all non-aspirin NSAID medications includes detailed safety warnings. These warnings mention a potential increased risk of serious cardiovascular events and severe gastrointestinal issues like bleeding or ulcers. Regulatory information indicates that these risks can be elevated with prolonged use and higher doses of the medication.


Q: What are some common reasons a doctor might prescribe Baroc?

According to official sources, the general purpose of Baroc is to provide relief from pain, inflammation, and fever. The medication's role as an NSAID allows for systemic symptomatic relief. Studies have also been conducted to explore its specific use for managing conditions such as chronic low back pain.


Q: Are there any food or drinks that officially interact with Baroc?

Official regulatory labeling provides specific warnings regarding the consumption of alcohol while taking NSAIDs like Baroc. Regulatory information describes that consuming three or more alcoholic drinks daily while using NSAIDs is associated with an increased risk of serious gastrointestinal bleeding.


Q: Is Baroc considered a new drug or has it been around for a while?

The active ingredient in Baroc, ibuprofen, is a well-established compound that has been in use for many decades. It was first discovered in the 1960s and introduced globally shortly after. Because of its long history, the active ingredient is now widely available as a generic medication under numerous brand names.


Q: What is the recommended age group for Baroc use?

Official product information indicates that Baroc is used in both adult and pediatric populations. Specific dosing for children is determined based on body weight, and use in infants under six months of age is generally restricted without specialized instruction. Special consideration is noted for older adults, and regulatory guidelines address dosing principles specific to that population.


Q: Is it common to feel stomach upset after starting Baroc?

According to regulatory documents, adverse reactions involving the gastrointestinal system are among the most frequently reported. Reactions such as nausea and diarrhea are listed in the official safety profile as either "Very Common" or "Common" side effects of the medication.


Q: Can Baroc affect blood pressure readings?

Official safety information states that NSAID medications, including the active ingredient in Baroc, may be associated with changes in blood pressure. The medication has been linked to potential modest increases in blood pressure, and in some cases, the onset or worsening of pre-existing high blood pressure (hypertension).


Q: Is Baroc a controlled substance?

The active ingredient in Baroc, ibuprofen, is not scheduled or classified as a controlled substance by major regulatory bodies like the U.S. Drug Enforcement Administration.


Q: What should I do if a side effect of Baroc is bothering me?

Regulatory patient guidance advises that if a user experiences severe or clinically significant symptoms, such as those related to potential heart problems, stroke, or severe gastrointestinal issues, they should stop using the medication. Official leaflets note that if concerning side effects occur, consultation with a healthcare professional is indicated.


Q: How long does Baroc stay in your system?

Pharmacokinetic data from official sources describe the medicine's movement and elimination from the body. The half-life—the time for half the drug to be eliminated—is typically rapid, in the range of 1.9 to 2.2 hours. Most of the administered dose is eliminated from the urine within four hours of taking the medication.


Q: Is Baroc known to cause mood swings?

While the official product information does not list mood swings as a common side effect, safety databases have included reports of psychiatric disorders and specific issues like sleep disturbances associated with the active ingredient. Official safety information notes that dizziness and insomnia are listed as common side effects.


Q: Can men and women use Baroc for the same conditions?

Baroc is generally indicated for the relief of pain, inflammation, and fever in both men and women. The standard approved uses are described as generally applicable to both genders. While research may examine the drug in the context of sex-specific conditions, such as Polycystic Ovary Syndrome in women, these are separate from the primary regulatory indications.


Q: Is it typical for Baroc to take several weeks to show an effect?

For general pain and fever, Baroc is often used for rapid, short-term relief. However, when the medication is prescribed for chronic conditions, such as those studied in clinical trials, the trial periods typically run for up to 12 weeks to assess the full, sustained reduction in symptoms.


Q: Do most people stop taking Baroc abruptly or gradually?

For short-term use, which is common for over-the-counter administration, discontinuation is typically abrupt. Regulatory guidance concerning prolonged use notes that consultation with a professional is indicated if use extends beyond ten days.


Q: Is there a generic version of Baroc available?

Yes, the active component of Baroc, ibuprofen, is a well-established generic compound. It is available under many different brand names and as a generic over-the-counter product globally.


Q: Can Baroc affect my ability to drive?

Official safety documents state that Baroc can cause side effects such as dizziness and drowsiness. Because these effects may impair alertness and coordination, official guidance indicates that they can affect a person's ability to safely drive or operate heavy machinery.


Q: Does Baroc interact with caffeine?

Regulatory drug interaction databases generally report no known interaction between caffeine and Baroc (single-ingredient ibuprofen). However, interactions between two substances can be complex. Users are directed to review the full label warnings for comprehensive information.


Q: What happens if Baroc is taken by someone who shouldn't take it?

When the medication is taken despite contraindications, the risks for which the warnings were established may increase. For example, official labeling warns that taking the drug when contraindicated can lead to an increased risk of severe adverse events, including cardiovascular issues or severe gastrointestinal bleeding.


Q: Are there common signs that Baroc is working?

According to the drug's mechanism of action and clinical trial outcomes, the expected signs that Baroc is working are a reduction in the primary symptoms it is intended to treat. These include a reported decrease in pain intensity, reduction in fever, and lessening of inflammation.


Q: Is it possible to become dependent on Baroc?

Baroc's active ingredient, ibuprofen, is not classified as a controlled substance by regulatory bodies. It is not considered to be habit-forming or associated with the potential for physical dependence.

How should Baroc be stored and disposed of?

How to Store and Dispose of Baroc (Ibuprofen)

Baroc (ibuprofen) must be stored according to official regulatory requirements to maintain product stability and effectiveness.

Storage Requirements

Condition Requirement
Temperature Store at Controlled Room Temperature (20 C to 25 C / 68 F to 77 F).
Protection Protect from excessive heat and moisture; store in a dry place.
Packaging Keep the product in its original container and ensure the container is tightly closed.
Child Safety The medicine must be kept strictly out of the sight and reach of children.

Disposal

Unused or expired Baroc must be disposed of in accordance with local requirements. The most recommended method is using an authorized drug take-back program. Ibuprofen should not be discarded into wastewater due to potential environmental risk.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Baroc found in:

A-Z Index: